Jane Yanagawa - Concepedia

Author

Jane Yanagawa

University of California, Los Angeles ORCID

Also Known As

J Yanagawa, J. Yanagawa, JANE YANAGAWA, Jane Yanagawa, S Kotova, Yanagawa, Jane

193

Publications

6.2K

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles UCLA Jonsson Comprehensive Cancer Center Memorial Sloan Kettering Cancer Center The University of Texas MD Anderson Cancer Center Cleveland Clinic

About

Jane Yanagawa is an author at University of California, Los Angeles specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	3.2K
2	Cell Biology	5	5	823
3	Health Sciences	4	4	1.4K
4	Public Health	3	3	75
5	Anatomy	1	1	14

Jane Yanagawa

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Journal of the National Comprehensive Cancer Network Version 3.2022Advanced Lung DiseaseMedicineCancer ManagementMetastatic Nsclc	2022	1.4K
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021 David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Journal of the National Comprehensive Cancer Network	2021	990
Non–Small Cell Lung Cancer, Version 4.2024 Gregory J. Riely, Douglas E. Wood, David S. Ettinger, Journal of the National Comprehensive Cancer Network Tumor BiologyActionable Molecular BiomarkersAdvanced Lung DiseaseVersion 4.2024Medicine	2024	614
NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023 David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Journal of the National Comprehensive Cancer Network	2023	449
Smoking and Lung Cancer: The Role of Inflammation Tonya C. Walser, Xiaoyan Cui, Jane Yanagawa, Proceedings of the American Thoracic Society InflammationTobacco ControlTumor BiologyInflammatory Lung DiseaseLung Carcinogenesis Proceeds	2008	376
Phase I Trial of Intratumoral Injection of<i>CCL21</i>Gene–Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration Jay M. Lee, Mi-Heon Lee, Edward B. Garon, Clinical Cancer Research	2017	220
The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma Milica Momcilovic, Sean T. Bailey, Jason T. Lee, Cancer Cell Tumor BiologyMedicineCancer BiologyTumor SuppressorRadiation Oncology	2018	178
Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma Claudio Scafoglio, Brendon Villegas, Gihad Abdelhady, Science Translational Medicine	2018	166
Organoids Model Transcriptional Hallmarks of Oncogenic KRAS Activation in Lung Epithelial Progenitor Cells Antonella F. M. Dost, Aaron L. Moye, Marall Vedaie, Cell stem cell Transcriptional RegulationDevelopmental BiologyOncogenic Kras ActivationBronchial NeoplasmGene Expression	2020	162
Quality of patient‐reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient‐reported outcome extension: A pooled analysis of 557 trials Fabio Efficace, Peter Fayers, Andrea L. Pusic, Cancer	2015	125

Page 1